Brocacef Group, a pharmaceutical sevices & ICT services, agreed to acquire 20 Dutch pharmacies from Ceban Pharmaceuticals, a pharmaceutical company. Financial terms were not disclosed. “With the acquisition of the compounding activities of Brocacef Ziekenhuisfarmacie, Ceban Compounding strengthens its position on the Dutch market for drug compounding, both extramural and intramural. The acquisition contributes to the growth of Ceban Pharmaceuticals and its ambition to become a leader in Europe in the field of compounding,” Jeroen van der Hamsvoort, Ceban Pharmaceuticals CEO.